Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("CREAGER, Mark A")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 70

  • Page / 3
Export

Selection :

  • and

The pharmacokinetics of cilostazolCREAGER, Mark A.Clinical pharmacokinetics. 1999, Vol 37, issn 0312-5963, 98 p., SUP2Serial Issue

Direct effect of ethanol on human vascular functionTAWAKOL, Ahmed; OMLAND, Torbjørn; CREAGER, Mark A et al.American journal of physiology. Heart and circulatory physiology. 2004, Vol 55, Num 6, pp 2468-2473, issn 0363-6135, 6 p.Article

Effect of omeprazole on the metabolism of cilostazolSURI, A; BRAMER, S. L.Clinical pharmacokinetics. 1999, Vol 37, pp 53-59, issn 0312-5963, SUP2Article

Inhibition of CYP2D6 by quinidine and its effects on the metabolism of cilostazolBRAMER, S. L; SURI, A.Clinical pharmacokinetics. 1999, Vol 37, pp 41-51, issn 0312-5963, SUP2Article

Effect of cilostazol on the pharmacokinetics and pharmacodynamics of warfarinMALLIKAARJUN, S; BRAMER, S. L.Clinical pharmacokinetics. 1999, Vol 37, pp 79-86, issn 0312-5963, SUP2Article

A randomized trial of iloprost in patients with intermittent claudicationCREAGER, Mark A; PANDE, Reena L; HIATT, William R et al.Vascular medicine (London). 2008, Vol 13, Num 1, pp 5-13, issn 1358-863X, 9 p.Article

Effect of hepatic impairment on the pharmacokinetics of a single dose of cilostazolBRAMER, S. L; FORBES, W. P.Clinical pharmacokinetics. 1999, Vol 37, pp 25-32, issn 0312-5963, SUP2Article

Acute Limb IschemiaCREAGER, Mark A; KAUFMAN, John A; CONTE, Michael S et al.The New England journal of medicine. 2012, Vol 366, Num 23, pp 2198-2206, issn 0028-4793, 9 p.Article

Endothelial function during stimulation of renin-angiotensin system by low-sodium diet in humansOMLAND, Torbjørn; JOHNSON, Wendy; GORDON, Mary Beth et al.American journal of physiology. Heart and circulatory physiology. 2001, Vol 49, Num 5, pp H2248-H2254, issn 0363-6135Article

Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial diseaseMOHLER, Emile R; HIATT, William R; CREAGER, Mark A et al.Circulation (New York, N.Y.). 2003, Vol 108, Num 12, pp 1481-1486, issn 0009-7322, 6 p.Article

Role of nitric oxide in the regulation of digital pulse volume amplitude in humansNOHRIA, Anju; GERHARD-HERMAN, Marie; CREAGER, Mark A et al.Journal of applied physiology (1985). 2006, Vol 101, Num 2, pp 545-548, issn 8750-7587, 4 p.Article

Endothelial function varies according to insulin resistance disease typeBECKMAN, Joshua A; GOLDFINE, Allison B; DUNAIF, Andrea et al.Diabetes care. 2007, Vol 30, Num 5, pp 1226-1232, issn 0149-5992, 7 p.Article

Mandate for creation of a National peripheral arterial Disease Public Awareness program: An opportunity to improve cardiovascular HealthHIRSCH, Alan T; GLOVICZKI, Peter; DROOZ, Alain et al.Angiology. 2004, Vol 55, Num 3, pp 233-242, issn 0003-3197, 10 p.Article

Interaction potential and tolerability of the coadministration of cilostazol and aspirinMALLIKAARJUN, S; FORBES, W. P; BRAMER, S. L et al.Clinical pharmacokinetics. 1999, Vol 37, pp 87-93, issn 0312-5963, SUP2Article

Cilostazol pharmacokinetics after single and multiple oral doses in healthy males and patients with intermittent claudication resulting from peripheral arterial diseaseBRAMER, S. L; FORBES, W. P; MALLIKAARJUN, S et al.Clinical pharmacokinetics. 1999, Vol 37, pp 1-11, issn 0312-5963, SUP2Article

Metabolic Syndrome, Inflammation, and Risk of Symptomatic Peripheral Artery Disease in Women A Prospective StudyCONEN, David; REXRODE, Kathryn M; CREAGER, Mark A et al.Circulation (New York, N.Y.). 2009, Vol 120, Num 12, pp 1041-1047, issn 0009-7322, 7 p.Article

Serum Total Bilirubin Level and Prevalent Lower-Extremity Peripheral Arterial Disease : National Health and Nutrition Examination Survey (NHANES) 1999 to 2004PERLSTEIN, Todd S; PANDE, Reena L; BECKMAN, Joshua A et al.Arteriosclerosis, thrombosis, and vascular biology. 2008, Vol 28, Num 1, pp 166-172, issn 1079-5642, 7 p.Article

Comparison of endothelial function in young men and women with a family history of premature coronary artery diseaseHAMBURG, Naomi M; CHARBONNEAU, Francois; GERHARD-HERMAN, Marie et al.The American journal of cardiology. 2004, Vol 94, Num 6, pp 783-785, issn 0002-9149, 3 p.Article

Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part ICREAGER, Mark A; LÜSCHER, Thomas F; COSENTINO, Francesco et al.Circulation (New York, N.Y.). 2003, Vol 108, Num 12, pp 1527-1532, issn 0009-7322, 6 p.Article

Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part IILÜSCHER, Thomas F; CREAGER, Mark A; BECKMAN, Joshua A et al.Circulation (New York, N.Y.). 2003, Vol 108, Num 13, pp 1655-1661, issn 0009-7322, 7 p.Article

Secondary Prevention and Mortality in Peripheral Artery Disease: National Health and Nutrition Examination Study, 1999 to 2004PANDE, Reena L; PERLSTEIN, Todd S; BECKMAN, Joshua A et al.Circulation (New York, N.Y.). 2011, Vol 124, Num 1, pp 17-23, issn 0009-7322, 7 p.Article

Association of Insulin Resistance and Inflammation With Peripheral Arterial Disease : The National Health and Nutrition Examination Survey, 1999 to 2004PANDE, Reena L; PERLSTEIN, Todd S; BECKMAN, Joshua A et al.Circulation (New York, N.Y.). 2008, Vol 118, Num 1, pp 33-41, issn 0009-7322, 9 p.Article

The contribution of nitric oxide to exercise hyperemia in the human forearmGORDON, Mary Beth; JAIN, Rajiv; BECKMAN, Joshua A et al.Vascular medicine (London). 2002, Vol 7, Num 3, pp 163-168, issn 1358-863X, 6 p.Article

Effect of multiple cilostazol doses on single dose Lovastatin pharmacokinetics in healthy volunteersBRAMER, S. L; BRISSON, J; COREY, A. E et al.Clinical pharmacokinetics. 1999, Vol 37, pp 69-77, issn 0312-5963, SUP2Article

Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD)GOLDFINE, Allison B; STEWART BUCK, J; DESOUZA, Cyrus et al.Diabetes care. 2013, Vol 36, Num 12, pp 4132-4139, issn 0149-5992, 8 p.Article

  • Page / 3